Advertisement

Serous Papillary Carcinoma of Cervix: A Clinicopathological Dilemma

  • Niharika Bisht
  • Sankalp SinghEmail author
  • Abhishek Purkayastha
  • Divya Shelly
  • Geetu Bhandoria
  • Deepak Mulajker
Case Report

Abstract

Serous papillary carcinoma of the cervix is a rare variant of the adenocarcinoma of the cervix with less than 50 cases reported worldwide. There are no clear guidelines for the management of this particular subtype, and the treatment is tailor-made based on retrospective analysis and the physician’s discretion. We present a case of locally advanced papillary serous cancer cervix that was managed radically with concurrent chemoradiotherapy and is presently disease free on follow-up.

Keywords

Serous papillary carcinoma cervix Radiotherapy Chemotherapy 

Notes

Compliance with Ethical Standards

Conflict of interest

None.

Human and Animal Rights Statement

This research does not involve any experimental interventions on humans or animals.

Informed Consent

Informed consent from the patient has been obtained.

References

  1. 1.
    Power DG, McVey GP, Delaney DW, et al. Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: a report of two cases. Acta Oncol. 2008;47:1590–3.CrossRefGoogle Scholar
  2. 2.
    Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol. 1998;22(1):113–20.CrossRefGoogle Scholar
  3. 3.
    Tang W, Zhang Z, Yao H, Zeng Z, Wan G. Papillary serous carcinoma of the cervix mixed with squamous cells: a report of the first case. Gynecol Oncol Case Rep. 2013;6:22–4.  https://doi.org/10.1016/j.gynor.2013.07.003.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Nofech-Mozes S, Rasty G, Ismiil N, Covens A, Khalifa MA. Immunohistochemical characterization of endocervical papillary serous carcinoma. Int J Gynecol Cancer. 2006;16(supplement 1):286–92.CrossRefGoogle Scholar
  5. 5.
    Ueda M, Koshiyama M, Yamaguchi A, et al. Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy. Rare Tumors. 2012;4(1):1–3.CrossRefGoogle Scholar
  6. 6.
    Khan M, Gilman AD, Nizami S, Barbaryan A, Ali AM, Mirrakhimov AE. Papillary serous carcinoma of the uterine cervix with lung metastasis. Case Rep Oncol Med. 2014;2014:683103.  https://doi.org/10.1155/2014/683103.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;84:420–7.CrossRefGoogle Scholar
  8. 8.
    Koshiyama M, Kinezaki M, Uchida T, et al. Chemosensitivity testing of paclitaxel versus docetaxel in human gynecological carcinomas: a comparison with carboplatin. Anticancer Res. 2006;26:3655–60.PubMedGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Malignant Disease Treatment CentreCommand Hospital (SC)PuneIndia
  2. 2.Department of Radiotherapy, Malignant Disease Treatment CentreCommand Hospital (CC)LucknowIndia
  3. 3.Department of PathologyArmed Forces Medical CollegePuneIndia
  4. 4.Department of Obstetrics and GynaecologyCommand Hospital (SC)PuneIndia

Personalised recommendations